A coalition of 11 educational establishments and their network partners in California won a $4. 1 million grant from the National Institutes of Health for a state network to combat COVID-19 among populations that have been disproportionately affected by the pandemic.
UCLA researchers will lead the coalition, called the COVID-19 California Alliance, or STOP COVID-19 CA, which is part of the NIH Broader Community Engagement Alliance that opposes COVID-19 disparities. The partnership is the result of a joint effort between five universities on California medical campuses, two other UC campuses, and 4 other leading educational establishments in California.
“This vital collaboration will come with 11 primary establishments with cutting-edge study projects in partnership with netpaintings,” said lead co-researcher Dr. Arleen Brown, professor of medicine at UCLA’s David Geffen School of Medicine and co-leader of netpainting participation. and curriculum at the UCLA Institute of Clinical and Translational Sciences. “These establishments live and paint in various communities with the highest rates of COVID-19 infections and headaches in the state. The contribution of networked paintings makes all the difference in those projects.
Each STOP COVID-19 CA site will depend on locally informed approaches, leveraging unique partnership networks and wisdom within each network to solve local problems. In Los Angeles, for example, researchers plan to organize teams of virtual concentrates in depth with multiple ethnic communities to identify barriers and demanding situations for vaccine progress and inclusive immunizations. Another task would assess racial and ethnic attitudes among high-risk veterans that would possibly prevent them from accepting a possible vaccine and expand messages to inspire vaccination among these Lessons learned from these efforts will help identify implementation opportunities across the state and country.
“In the early stages of the pandemic, we saw that the disproportionate effect of COVID-19 on black, Latino and indigenous communities and other minority groups,” dr. Carrie L. Byington, Executive Vice President of Health at the University of California and an expert on infectious diseases. “We’ve expanded reach, testing, and care to help those communities quickly. “
The next one in this fight is even more crucial, he added.
“We want to earn the acceptance of the communities whose reports lived possibly predispose them to skepticism,” Byington said. “We will have to actively pay attention and respond to considerations with respect through understanding, transparency and sustained action. The STOP COVID-19 initiative combines interdisciplinary collaboration with the network’s commitment to making connections that will be critical to ending the pandemic for all.
NiH Community Engagement Alliance study groups in 11 states will conduct studies on awareness and schooling at COVID-19, i. e. among black, Latino and indigenous populations, representing more than all cases reported in the United States, said Dr. Keith Norris, professor of medicine and vice president of the Office of Diversity and Inclusion EquityArray of the Department of Medicine at Geffen Medical School.
“The objectives of STOP COVID-19 CA are to paint with this network paintings of associations throughout the state to reduce disparities in the wisdom of COVID-19; Increase the participation of all Californians, adding underrepresented populations, in prevention, vaccination and healing trials; and the use of approved vaccines,” said Norris, who is also co-director of the project.
STOP COVID-19 CA is strongly aligned with the Translational Science Centers on 8 of the coalition campuses that are funded through the NIH Clinical and Translational Science Awards, or CTSA. CTSA will provide access to study resources, adding biostatistics and experience in conducting studies on physical fitness disparities and studies in partnership with the community. In addition, 3 campuses are funded through NIH resource centers in minority institutions, or RCMI program.
“This is a remarkable example of what we can achieve through our CTSA and RCMI,” said Dr. Steven Dubinett, project co-leader and director of the UCLA Institute of Clinical and Translational Sciences, one of CTSA’s sites. “It is a necessity- We need to expand effective and committed methods in the network to improve education, awareness, access and inclusion of under-neglected communities in studies aimed at promoting coVID-19 prevention and remedy and reducing disparities.
The NIH grant is one year and began on September 9, 2020.
In addition to UCLA (coordination site), your spouse at the Institute of Clinical and Translational Sciences, Charles R. University Drew and network spouses across the state, STOP COVID-19 CA collaboration sites come with UC Davis, UC Irvine, UC Merced, UC Riverside, UC San Diego, UC San Francisco, University of Southern California, Stanford University, Scripps Research and San Diego State University.
Get search titles and news 4 days a week
(Check your inbox or delete spam to confirm).
Subscribe to an RSS channel in the UCLA newsroom and our titles will be sent to your news reader.